A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
Public ClinicalTrials.gov record NCT03844932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis
Study identification
- NCT ID
- NCT03844932
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Sublimity Therapeutics Holdco Limited
- Industry
- Enrollment
- 235 participants
Conditions and interventions
Conditions
Interventions
- ST-0529 Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 23, 2019
- Primary completion
- Apr 13, 2021
- Completion
- Apr 13, 2021
- Last update posted
- May 6, 2021
2019 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Palmtree Clinical Research Inc | Palm Springs | California | 92262 | — |
| Advanced Research Institute | Largo | Florida | 33377 | — |
| Advanced Research Institute, Inc. | New Port Richey | Florida | 34653 | — |
| Endoscopic Research Inc | Orlando | Florida | 32803 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| AGA Clinical Reasearch Associates, LLC | Egg Harbor | New Jersey | 08234 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Biopharma Informatic, LLC. | Houston | Texas | 77084 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 81 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03844932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 6, 2021 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03844932 live on ClinicalTrials.gov.